Forbes Medi-Tech Inc. (USA) 

(Public, NASDAQ:FMTI)   Watch this stock   
Find more results for FMTI
Nov 9, 2009
Q3 2009 Forbes Medi-Tech Earnings Release
More events from AOL Finance »    

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin 5.86% -91.68%
Operating margin 4.29% -91.46%
EBITD margin - -98.47%
Return on average assets 5.75% -64.88%
Return on average equity 8.40% -115.72%
Employees 15 -

Address

750 West Pender Street Suite 200
Vancouver, BC V6C 2T8
Canada
+1-604-6895899 (Phone)
+1-604-6897641 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

Forbes Medi-Tech Inc. (USA) discussions

  View all discussions »

Description

Forbes Medi-Tech Inc. (Forbes) is a life sciences company focused on evidence-based nutritional solutions. Forbes is a provider of products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Forbes has developed and commercialized its Reducol plant sterol blend. In August 2008, Forbes completed the sale of its pharmaceutical assets and business unit based in San Diego, California to Transition Therapeutics Inc. On February 27, 2008, Forbes Medi-Tech Operations Inc., a former wholly owned subsidiary of Forbes (Old Forbes) changed its name from Forbes Medi-Tech Inc. to Forbes Medi-Tech Operations Inc. On May 12, 2008, Old Forbes changed its name from Forbes Medi-Tech Operations Inc. to 3887685 Canada Inc. and subsequently, on February 9, 2009, Old Forbes changed its name from 3887685 Canada Inc. to Deans Knight Income Corporation.

Officers and directors

Joe Dunne Ph.D.
Chairman of the Board
Age: 67
Bio & Compensation - Reuters
Charles A. Butt
President, Chief Executive Officer, Director
Age: 58
Bio & Compensation - Reuters
David Goold
Chief Financial Officer
Portrait. Age: 54
Bio & Compensation - Reuters
Laura Wessman
Senior Vice President - Operations
Portrait. Age: 42
Bio & Compensation - Reuters
David Stewart Ph.D.
Vice President, Regulatory Affairs
Age: 68
Bio & Compensation - Reuters
Nitin Kaushal
Director
Age: 44
Bio & Compensation - Reuters
Greg Anderson
Director
Age: 62
Bio & Compensation - Reuters